Hepatic fibrosis - and not steatosis - is the main determinant of arterial stiffness in non-alcoholic fatty liver disease

被引：2
|
作者：
Yilmaz, Yusuf [1 ,2 ]
Eren, Fatih [2 ,3 ]
机构：
[1] Marmara Univ, Sch Med, Dept Gastroenterol, Istanbul, Turkey
[2] Marmara Univ, Inst Gastroenterol, Istanbul, Turkey
[3] Marmara Univ, Sch Med, Dept Med Biol, Istanbul, Turkey
来源：
ATHEROSCLEROSIS | 2019年 / 290卷
关键词：
Fibroscan; Transient elastography; Arterial stiffness; Liver fibrosis; Hepatic steatosis;
D O I：
10.1016/j.atherosclerosis.2019.07.020
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：222 / 223
页数：2
相关论文
共 50 条
  • [1] Reply to: "Hepatic fibrosis - and not steatosis - is the main determinant of arterial stiffness in nonalcoholic fatty liver disease"
    Styczynski, Grzegorz
    Kalinowski, Piotr
    Michalowski, Lukasz
    Paluszkiewicz, Rafal
    Ziarkiewicz-Wroblewska, Bogna
    Zieniewicz, Krzysztof
    Tataj, Emanuel
    Szmigielski, Cezary
    Jedrusik, Piotr
    [J]. ATHEROSCLEROSIS, 2019, 290 : 224 - 225
  • [2] Assessment of hepatic steatosis algorithms in non-alcoholic fatty liver disease
    Eremic-Kojic, N.
    Deric, M.
    Govorcin, M. L.
    Balac, D.
    Kresoja, M.
    Kojic-Damjanov, S.
    [J]. HIPPOKRATIA, 2018, 22 (01) : 10 - 16
  • [3] Assessment of hepatic steatosis algorithms in non-alcoholic fatty liver disease
    Kojic, N. Eremic
    [J]. CLINICA CHIMICA ACTA, 2019, 493 : S362 - S362
  • [4] Risk factors for hepatic steatosis in adults with cystic fibrosis: Similarities to non-alcoholic fatty liver disease
    Fares Ayoub
    Cesar Trillo-Alvarez
    Giuseppe Morelli
    Jorge Lascano
    [J]. World Journal of Hepatology, 2018, 10 (01) : 34 - 40
  • [5] Inhibiting Ceramide Synthesis Attenuates Hepatic Steatosis and Fibrosis in Rats With Non-alcoholic Fatty Liver Disease
    Jiang, Meng
    Li, Chun
    Liu, Qiaoshu
    Wang, Aimin
    Lei, Minxiang
    [J]. FRONTIERS IN ENDOCRINOLOGY, 2019, 10
  • [6] Risk factors for hepatic steatosis in adults with cystic fibrosis: Similarities to non-alcoholic fatty liver disease
    Ayoub, Fares
    Trillo-Alvarez, Cesar
    Morelli, Giuseppe
    Lascano, Jorge
    [J]. WORLD JOURNAL OF HEPATOLOGY, 2018, 10 (01) : 34 - 40
  • [7] The ""Fatty Liver Index" and "Non Alcoholic Fatty Liver Disease liver fat score" in subjects at risk of non-alcoholic hepatic steatosis Relationship with hepatic fibrosis and cardiovascular risk
    Jaber, Y.
    Cosson, E.
    Nguyen, M. T.
    Takbou, K.
    Pucheu, N.
    Valensi, P.
    [J]. DIABETES & METABOLISM, 2011, 37 : A86 - A87
  • [8] Non-alcoholic fatty liver disease is associated with progression of arterial stiffness
    Li, N.
    Zhang, G. -W.
    Zhang, J. -R.
    Jin, D.
    Li, Y.
    Liu, T.
    Wang, R. -T.
    [J]. NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES, 2015, 25 (02) : 218 - 223
  • [9] Free Triiodothyronine Is Associated With Hepatic Steatosis and Liver Stiffness in Euthyroid Chinese Adults With Non-Alcoholic Fatty Liver Disease
    Guo, Wen
    Qin, Pei
    Li, Xiao-Na
    Wu, Juan
    Lu, Jing
    Zhu, Wen-Fang
    Diao, Qing-qing
    Xu, Nian-Zhen
    Zhang, Qun
    [J]. FRONTIERS IN ENDOCRINOLOGY, 2021, 12
  • [10] Human relaxin-2 attenuates hepatic steatosis and fibrosis in mice with non-alcoholic fatty liver disease
    Lee, Kuei-Chuan
    Hsieh, Yun-Cheng
    Chan, Che-Chang
    Sun, Hao-Jhe
    Huang, Yi-Hsiang
    Hou, Ming-Chih
    Lin, Han-Chieh
    [J]. LABORATORY INVESTIGATION, 2019, 99 (08) : 1203 - 1216
12345